These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 34261331

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial.
    Pfisterer M, Buser P, Osswald S, Allemann U, Amann W, Angehrn W, Eeckhout E, Erne P, Estlinbaum W, Kuster G, Moccetti T, Naegeli B, Rickenbacher P, Trial of Invasive versus Medical therapy in Elderly patients (TIME) Investigators.
    JAMA; 2003 Mar 05; 289(9):1117-23. PubMed ID: 12622581
    [Abstract] [Full Text] [Related]

  • 23. Comparison of outcomes of patients ≥ 80 years of age having percutaneous coronary intervention according to presentation (stable vs unstable angina pectoris/non-ST-segment elevation myocardial infarction vs ST-segment elevation myocardial infarction).
    Antonsen L, Jensen LO, Thayssen P, Christiansen EH, Junker A, Tilsted HH, Terkelsen CJ, Kaltoft A, Maeng M, Hansen KN, Ravkilde J, Lassen JF, Madsen M, Sørensen HT, Thuesen L.
    Am J Cardiol; 2011 Nov 15; 108(10):1395-400. PubMed ID: 21890087
    [Abstract] [Full Text] [Related]

  • 24. Approach to stable angina in patients with advanced chronic kidney disease.
    Arif H, Yadav A.
    Curr Opin Nephrol Hypertens; 2021 May 01; 30(3):339-345. PubMed ID: 33767062
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Residual high-grade angina after enhanced external counterpulsation therapy.
    McCullough PA, Henry TD, Kennard ED, Kelsey SF, Michaels AD, IEPR Investigators.
    Cardiovasc Revasc Med; 2007 May 01; 8(3):161-5. PubMed ID: 17765644
    [Abstract] [Full Text] [Related]

  • 27. Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.
    Arnold SV, Magnuson EA, Wang K, Serruys PW, Kappetein AP, Mohr FW, Cohen DJ, SYNTAX Investigators.
    Circ Cardiovasc Qual Outcomes; 2012 May 01; 5(3):267-75. PubMed ID: 22496114
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Successful revascularization versus medical therapy in diabetic patients with stable right coronary artery chronic total occlusion: a retrospective cohort study.
    Yan Y, Zhang M, Yuan F, Liu H, Wu D, Fan Y, Guo X, Xu F, Zhang M, Zhao Q, Lyu S.
    Cardiovasc Diabetol; 2019 Aug 21; 18(1):108. PubMed ID: 31434572
    [Abstract] [Full Text] [Related]

  • 34. Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.
    Spertus JA, Maron DJ, Cohen DJ, Kolm P, Hartigan P, Weintraub WS, Berman DS, Teo KK, Shaw LJ, Sedlis SP, Knudtson M, Aslan M, Dada M, Boden WE, Mancini GB, Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Investigators and Coordinators.
    Circ Cardiovasc Qual Outcomes; 2013 Jul 21; 6(4):409-18. PubMed ID: 23838107
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Stable angina: current state of disease management.
    Dobesh PP.
    J Manag Care Pharm; 2006 Oct 21; 12(8 Suppl):S4-9. PubMed ID: 23577422
    [Abstract] [Full Text] [Related]

  • 38. Relationships Between Components of Blood Pressure and Cardiovascular Events in Patients with Stable Coronary Artery Disease and Hypertension.
    Vidal-Petiot E, Greenlaw N, Ford I, Ferrari R, Fox KM, Tardif JC, Tendera M, Parkhomenko A, Bhatt DL, Steg PG.
    Hypertension; 2018 Jan 21; 71(1):168-176. PubMed ID: 29084876
    [Abstract] [Full Text] [Related]

  • 39. Randomized All-Comers Evaluation of a Permanent Polymer Zotarolimus-Eluting Stent Versus a Polymer-Free Amphilimus-Eluting Stent.
    Rozemeijer R, Stein M, Voskuil M, van den Bor R, Frambach P, Pereira B, Koudstaal S, Leenders GE, Timmers L, Rittersma SZ, Kraaijeveld AO, Agostoni P, Roes KC, Doevendans PA, Stella PR, ReCre8 Study Investigators.
    Circulation; 2019 Jan 02; 139(1):67-77. PubMed ID: 30586704
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.